  0 Table of Contents |
  1 Home |
| 2 Background |
| 3 Downloads |
| 4 Use Cases |
 5 Artifacts Summary |
 5.1 Kenya ePrescription Server CapabilityStatement |
| 5.2 SearchParameter – AllergyIntolerance Substance Code |
| 5.3 SearchParameter – Encounter ServiceProvider |
| 5.4 SearchParameter – MedicationDispense Prescription |
| 5.5 SearchParameter – MedicationDispense WhenHandedOver |
| 5.6 SearchParameter – MedicationRequest AuthoredOn |
| 5.7 SearchParameter – MedicationRequest Identifier |
| 5.8 SearchParameter – MedicationRequest Medication Code |
| 5.9 SearchParameter – Provenance Recorded |
| 5.10 SearchParameter – Provenance Target |
| 5.11 Kenya eRx AllergyIntolerance |
| 5.12 Kenya eRx Encounter |
| 5.13 Kenya eRx EpisodeOfCare |
| 5.14 Kenya eRx Medication |
| 5.15 Kenya eRx MedicationAdministration |
| 5.16 Kenya eRx MedicationDispense |
| 5.17 Kenya eRx MedicationRequest |
| 5.18 Kenya eRx MedicationStatement |
| 5.19 Kenya eRx Provenance |
| 5.20 Controlled Substance Schedule |
| 5.21 Dispense Notification |
| 5.22 Insurance Pre-Authorization |
| 5.23 Prescription Digital Signature |
| 5.24 Refill Authorization |
| 5.25 Active Components ValueSet |
| 5.26 Additional Instruction Codes ValueSet |
| 5.27 Approach Site Codes ValueSet |
| 5.28 Care Plan Category ValueSet |
| 5.29 Condition Category ValueSet |
| 5.30 Condition Clinical Status ValueSet |
| 5.31 Condition Codes ValueSet |
| 5.32 Condition Severity ValueSet |
| 5.33 Condition Stage ValueSet |
| 5.34 Condition Verification Status ValueSet |
| 5.35 Controlled Substance Schedule ValueSet |
| 5.36 Formulation (Dosage Form) ValueSet |
| 5.37 Generic Products ValueSet |
| 5.38 ICD-11 Codes ValueSet |
| 5.39 Kenya Episode of Care Type ValueSet |
| 5.40 Kenya eRx Episode of Care Type ValueSet |
| 5.41 Manifestation or Symptom ValueSet |
| 5.42 Medication Administration Route ValueSet |
| 5.43 Medication Request Priority ValueSet |
| 5.44 MedicationAdministration Status Reason ValueSet |
| 5.45 MedicationDispense Status Reason ValueSet |
| 5.46 MedicationRequest Status Reason ValueSet |
| 5.47 MedicationRequest Status ValueSet |
| 5.48 Observation Methods ValueSet |
| 5.49 Procedure Code ValueSet |
| 5.50 Reason Medication Status ValueSet |
| 5.51 Route of Administration ValueSet |
| 5.52 Unit of Measure ValueSet |
| 5.53 Active Components CodeSystem |
| 5.54 Additional Instruction Codes CodeSystem |
| 5.55 Approach Site Codes CodeSystem |
| 5.56 Care Plan Category CodeSystem |
| 5.57 Condition Category CodeSystem |
| 5.58 Condition Clinical Status CodeSystem |
| 5.59 Condition Severity CodeSystem |
| 5.60 Condition Stage CodeSystem |
| 5.61 Condition Verification Status CodeSystem |
| 5.62 Controlled Substance Schedule CodeSystem |
| 5.63 Formulation CodeSystem |
| 5.64 Generic Products CodeSystem |
| 5.65 ICD-11 Code System |
| 5.66 Kenya Episode of Care Type CodeSystem |
| 5.67 Manifestation or Symptom CodeSystem |
| 5.68 Medication Administration Route CodeSystem |
| 5.69 Medication Request Priority CodeSystem |
| 5.70 MedicationAdministration Status Reason CodeSystem |
| 5.71 MedicationDispense Status Reason CodeSystem |
| 5.72 MedicationRequest Status CodeSystem |
| 5.73 MedicationRequest Status Reason CodeSystem |
| 5.74 Observation Methods CodeSystem |
| 5.75 Procedure Code CodeSystem |
| 5.76 Reason Medication Status CodeSystem |
| 5.77 Route of Administration CodeSystem |
| 5.78 Unit of Measure CodeSystem |
| 5.79 NamingSystem – Kenya Administration Identifier |
| 5.80 NamingSystem – Kenya Allergy Identifier |
| 5.81 NamingSystem – Kenya CarePlan Identifier |
| 5.82 NamingSystem – Kenya Condition Identifier |
| 5.83 NamingSystem – Kenya Dispense Identifier |
| 5.84 NamingSystem – Kenya Encounter Identifier |
| 5.85 NamingSystem – Kenya Episode of Care Identifier |
| 5.86 NamingSystem – Kenya Health Facility Code |
| 5.87 NamingSystem – Kenya Location Code |
| 5.88 NamingSystem – Kenya Medical Licence |
| 5.89 NamingSystem – Kenya Medication Identifier |
| 5.90 NamingSystem – Kenya MedicationStatement Identifier |
| 5.91 NamingSystem – Kenya National ID |
| 5.92 NamingSystem – Kenya Observation Identifier |
| 5.93 NamingSystem – Kenya Prescription Identifier |
| 5.94 AllergyIntolerance – Amina Hassan Penicillin Allergy |
| 5.95 AllergyIntolerance – INVALID: Missing recordedDate, invalid criticality, missing reaction severity |
| 5.96 Condition – James Otieno Lung Cancer |
| 5.97 Encounter – Amina Hassan Outpatient Consultation |
| 5.98 Encounter – INVALID: Missing participant/serviceProvider; wrong class code |
| 5.99 Encounter – James Otieno Oncology Inpatient Admission |
| 5.100 EpisodeOfCare – INVALID: Missing type, invalid status, wrong careManager type |
| 5.101 EpisodeOfCare – James Otieno Oncology Management |
| 5.102 Location – KNH Outpatient Pharmacy |
| 5.103 Medication – Azithromycin 500 mg Film-Coated Tablet |
| 5.104 Medication – INVALID: Missing identifier/form; wrong code binding |
| 5.105 MedicationAdministration – INVALID: Missing context; wrong route system; wrong subject type |
| 5.106 MedicationAdministration – James Otieno IV Azithromycin |
| 5.107 MedicationDispense – Amina Hassan Azithromycin First Fill |
| 5.108 MedicationDispense – Extension: Dispense Notification |
| 5.109 MedicationDispense – INVALID: Missing authorizingPrescription; wrong performer and medication |
| 5.110 MedicationRequest – Amina Hassan Azithromycin Prescription |
| 5.111 MedicationRequest – Extensions: Digital Signature, Refill, Controlled Substance, Insurance Auth |
| 5.112 MedicationRequest – INVALID: Missing dispenseRequest; wrong medication and route bindings |
| 5.113 MedicationStatement – Amina Hassan Completed Azithromycin Course |
| 5.114 MedicationStatement – INVALID: Wrong medication binding, wrong effective type, wrong info source |
| 5.115 Organization – Kenyatta National Hospital |
| 5.116 Patient – Amina Hassan |
| 5.117 Patient – James Otieno |
| 5.118 Practitioner – Dr. Sarah Njoroge |
| 5.119 Provenance – Administration Recorded by Dr. Njoroge (VALID) |
| 5.120 Provenance – Dispense Verified at KNH Pharmacy (VALID) |
| 5.121 Provenance – Medication Statement Asserted by Amina Hassan (VALID) |
 5.122 Provenance – Prescription Created by Dr. Njoroge (VALID) |
